JY
PLRX icon

Jeff Yass’s Pliant Therapeutics PLRX Stock Holding History

Jeff Yass’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6K Sell
15,480
-37,476
-71% -$45.6K ﹤0.01% 13065
2026
Q1 		$66.7K Buy
52,956
+18,755
+55% +$23.7K ﹤0.01% 12537
2025
Q4 		$41.7K Sell
34,201
-39,753
-54% -$59.7K ﹤0.01% 11815
2025
Q3 		$109K Sell
73,954
-96,032
-56% -$147K ﹤0.01% 11510
2025
Q2 		$197K Buy
169,986
+73,519
+76% +$104K ﹤0.01% 11231
2025
Q1 		$130K Buy
96,467
+27,893
+41% +$169K ﹤0.01% 11335
2024
Q4 		$903K Buy
68,574
+21,936
+47% +$299K ﹤0.01% 7214
2024
Q3 		$523K Buy
46,638
+17,202
+58% +$215K ﹤0.01% 8361
2024
Q2 		$316K Buy
29,436
+6,691
+29% +$86.3K ﹤0.01% 9328
2024
Q1 		$339K Sell
22,745
-54,862
-71% -$905K ﹤0.01% 9433
2023
Q4 		$1.41M Sell
77,607
-66,901
-46% -$1.02M ﹤0.01% 6150
2023
Q3 		$2.51M Buy
144,508
+85,624
+145% +$1.48M ﹤0.01% 4698
2023
Q2 		$1.07M Sell
58,884
-538,987
-90% -$12.8M ﹤0.01% 6530
2023
Q1 		$15.9M Buy
597,871
+172,975
+41% +$4.92M ﹤0.01% 1926
2022
Q4 		$8.21M Buy
424,896
+362,799
+584% +$7.58M ﹤0.01% 2529
2022
Q3 		$1.3M Buy
62,097
+12,305
+25% +$235K ﹤0.01% 5961
2022
Q2 		$399K Buy
+49,792
New +$319K ﹤0.01% 8818
2022
Q1 		– Sell
-29,103
Closed -$393K – 13746
2021
Q4 		$393K Buy
29,103
+11,955
+70% +$190K ﹤0.01% 9830
2021
Q3 		$289K Buy
17,148
+10,189
+146% +$216K ﹤0.01% 10685
2021
Q2 		$203K Sell
6,959
-18,639
-73% -$580K ﹤0.01% 11572
2021
Q1 		$1.01M Buy
25,598
+11,044
+76% +$359K ﹤0.01% 7724
2020
Q4 		$331K Sell
14,554
-23,113
-61% -$580K ﹤0.01% 9078
2020
Q3 		$853K Buy
+37,667
New +$941K ﹤0.01% 6504

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Jeff Yass's PLRX Position: Q2 2026 in Review

Jeff Yass reduced its Pliant Therapeutics (PLRX) stake by 71% in Q2 2026, selling an estimated $45.6K and leaving 15,480 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #13065.

Jeff Yass first reported a position in PLRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $15.9M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Jeff Yass held 15,480 shares of Pliant Therapeutics worth $17.6K as of Q2 2026.
  • Jeff Yass sold 37,476 Pliant Therapeutics shares in Q2 2026, an estimated $45.6K.
  • Pliant Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13065 holding.
  • Jeff Yass first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Jeff Yass's Pliant Therapeutics position peaked at $15.9M in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.